A retrospective analysis of five year data of end-stage renal disease patients: A single center experience

dc.contributor.authorTürkmen K.
dc.contributor.authorTunç A.
dc.contributor.authorSolak Y.
dc.contributor.authorTürk S.
dc.date.accessioned2020-03-26T18:22:08Z
dc.date.available2020-03-26T18:22:08Z
dc.date.issued2011
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractOBJECTIVES: CKD is a worldwide threat to public health. Approximately 1.8 million people are currently being treated with renal replacement therapy including hemodialysis, peritoneal dialysis and transplantation. The etiology and factors affecting the progression of chronic kidney disease to endstage renal disease (ESRD) differ in industrialized and underdeveloped countries. STUDY DESIGN: The aim of the study was to investigate the etiologies of ESRD, factors affecting progression to ESRD and mortality rates of patients between 2000-2004, in Konya, a city in the Middle Anatolian region of Turkey. MATERIAL and METHODS: We included 417 end-stage renal disease patients (207 female and 210 male) between 16-90 years old receiving RRT for the first time in the study. CKD was diagnosed by GFR measurement that was calculated by MDRD formula. Co-morbidity was expressed using Wright-Khan index. RESULTS: We showed that there was an increased rate of diabetic nephropathy between 2003 and 2004. The increased rate of diabetic nephropathy was found to be statistically significant in the last two years (p<0.005). There was also significant negative correlation between mortality and diastolic BP (r: -0.143, p: 0.05) and the education level of the patients (r: -0.159, p: 0.0002). There was a positive correlation between mortality and serum urea levels (r: 0.193, p: 0.0001), HD through a catheter for the first time (r: 0.140, p: 0.0006), and receiving HD by a continuous RRT modality (r: 0.163, p: 0.0001). CONCLISION: Our study showed that advanced age, increased mean arterial BP before the first RRT, having CVD or DM as an etiology of ESRD, increased erythrocyte sedimentation rate (ESR), decreased serum albumin levels and the presence of co-morbid diseases were the main factors that affected survival of the patients.en_US
dc.identifier.doi10.5262/tndt.2011.1002.07en_US
dc.identifier.endpage162en_US
dc.identifier.issn1300-7718en_US
dc.identifier.issue2en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage156en_US
dc.identifier.urihttps://dx.doi.org/10.5262/tndt.2011.1002.07
dc.identifier.urihttps://hdl.handle.net/20.500.12395/27174
dc.identifier.volume20en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.relation.ispartofTurkish Nephrology, Dialysis and Transplantation Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectDiabetesen_US
dc.subjectEnd-stage renal diseaseen_US
dc.subjectRenal replacement therapyen_US
dc.titleA retrospective analysis of five year data of end-stage renal disease patients: A single center experienceen_US
dc.typeArticleen_US

Dosyalar